Free Secrets to be a Healthy Women

Monte Carlo, Monaco, on Monday, May 14, 2007 The company also announced this month that it has completed enrollment in the Strong Study its phase II clinical trial of NB S101, the company’s investigational drug for osteoporosis. The study will focus on the enrolled 289 postmenopausal women with low bone mineral density; the primary endpoint in the trial is the change in patients’ bone resorption after the completion of the 12 week trial. And that’s our newsmakers, Stay tuned right here …